The preclinical discovery and development of bortezomib for the treatment of mantle cell lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The preclinical discovery and development of bortezomib for the treatment of mantle cell lymphoma

Published:2016-12-20 Issue:2 Volume:12 Page:225-235
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Arkwright Richard¹²,Pham Tri Minh³,Zonder Jeffrey A.¹²,Dou Q. Ping¹²³

Affiliation:

1. Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan, USA

2. Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, USA

3. Department of Pathology, Wayne State University School of Medicine, Detroit, Michigan, USA

Funder

National Cancer Institute

Publisher

Informa UK Limited

Subject

Drug Discovery

Link

https://www.tandfonline.com/doi/pdf/10.1080/17460441.2017.1268596

Reference97 articles.

1. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management

2. Which Patients With Mantle Cell Lymphoma Do Not Need Aggressive Therapy

3. Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives

4. Phase I Trial of the Proteasome Inhibitor PS-341 in Patients With Refractory Hematologic Malignancies

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapy Release From Bortezomib-Impregnated Polymethylmethacrylate-Coated Intramedullary Nails: A Novel In Vitro Study for a Local Chemotherapy Delivery Device;Cureus;2024-07-09

2. Chemical Proteomics Reveals that the Anticancer Drug Everolimus Affects the Ubiquitin–Proteasome System;ACS Pharmacology & Translational Science;2024-02-07

3. Asymmetric hydrogenation of boron-substituted olefin, enamine, and imine derivatives;Tetrahedron Letters;2023-12

4. The Search for Inhibitors of the Ubiquitin-proteasome System from Natural Sources by Cell-based Screening in Reporter-expressing Cells;Journal of Synthetic Organic Chemistry, Japan;2023-11-01

5. Chemical proteomics reveals that the anticancer drug everolimus affects ubiquitin-proteasome system;2023-10-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3